Lung cancer in the older individual is an increasingly common problem faced by the
oncologist. Elderly patients over 70years account about 40% of lung cancer patients …

Lung cancer is the leading cause of cancer related mortality worldwide. Non-small cell lung
cancer (NSCLC) accounts for 85% of all cases. Half of the patients at diagnosis of NSCLC …

Background A large proportion of elderly patients (> 70 years) with newly diagnosed NSCLC
are shown to be frail by a comprehensive geriatric assessment. This population is more …

More than 40% of cases of all lung cancers are diagnosed in patients over the age of 70
years. Elderly patients have more comorbidities and tend to be less tolerant to toxic medical …

Purpose The aim of this study was to compare single-agent chemotherapy with targeted
therapy in initial treatment and to explore a better choice of treatment for patients aged 80 …

Non-small cell lung cancer (NSCLC) may be considered typical of advanced age. More than
50% of NSCLC patients are diagnosed over the age of 65 and approximately one-third of all …

Objectives We evaluated the impact of age in a randomized phase II trial that compared
three first-line drugs in elderly patients with advanced non-small cell lung cancer (NSCLC) …

With a median age of 70 years at diagnosis, lung cancer is a disease of older persons. As a
consequence oncologists are confronted with an increasing older lung cancer population for …

Non‐small cell lung cancer (NSCLC) is the most lethal of the common solid malignancies. It
is predominantly a disease of the elderly with the median age at diagnosis 68 years …

Increases in both life expectancy and cancer incidence with age result in a significant rise in
lung cancer rates among elderly patients, with a median age at diagnosis of between 63 and …